Founded in 2001, Xerimis is a leading provider of clinical supply services for global trials, specializing in supporting small to mid-size pharmaceutical companies. Our headquarters in the US and full-service depots in the UK and Netherlands allow for servicing of trials of all sizes anywhere in the world. Serving pharmaceutical, biotechnology, and research organizations, we bring unmatched precision to every stage of your process and trial - from protocol development and plan generation, to labeling, shipping/distribution, and returns reconciliation. Xerimis’s superior standards yield strong client relationships rooted in trust, reliability, and dedication.
Looking for a particular Xerimis employee's phone or email?
The Xerimis annual revenue was $17.3 million in 2026.
James Locascio is the Chief Business Officer of Xerimis.
112 people are employed at Xerimis.
Xerimis is based in Moorestown, New Jersey.
The NAICS codes for Xerimis are [32541, 3254, 325, 32].
The SIC codes for Xerimis are [283, 28].